Indivior Pharmaceuticals, Inc. (INDV)
30.65
+0.17
(+0.56%)
USD |
NASDAQ |
Apr 01, 16:00
30.55
-0.10
(-0.33%)
Pre-Market: 09:00
Indivior Pharmaceuticals Research and Development Expense (TTM) : 80.00M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| CorMedix, Inc. | 19.33M |
| ANI Pharmaceuticals, Inc. | 51.66M |
| Amicus Therapeutics, Inc. | 135.84M |
| Liquidia Corp. | 38.35M |
| Pulse Biosciences, Inc. | 44.72M |